Of note, USP35 overexpression fails to affect tumorigenesis and ferroptosis under basal conditions, but reduces erastin/RSL3-triggered iron disturbance and ferroptosis, thereby facilitating lung cancer cell growth and tumor progression. This evidence concerns the gene USP35 and lung carcinoma.